157 related articles for article (PubMed ID: 33106982)
1. Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review.
Hedayati M; Abooshahab R; Razavi SA; Salehipour P; Ahmadikia K; Boroomand S
Mol Biol Rep; 2020 Nov; 47(11):8859-8866. PubMed ID: 33106982
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers.
Lawnicka H; Motylewska E; Borkowska M; Kuzdak K; Siejka A; Swietoslawski J; Stepien H; Stepien T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):77-83. PubMed ID: 31132076
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
[TBL] [Abstract][Full Text] [Related]
5. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Fanaei SA; Hedayati M; Azizi F
BMC Cancer; 2018 Dec; 18(1):1199. PubMed ID: 30509240
[TBL] [Abstract][Full Text] [Related]
6. Elevated Plasma Levels of MT4-MMP and MT6-MMP; A New Observation in Patients with Thyroid Nodules.
Shirazkeytabar K; Razavi SA; Abooshahab R; Salehipour P; Akbarzadeh M; Soroush A; Hedayati M; Nasiri S
Arch Iran Med; 2023 Jun; 26(6):338-345. PubMed ID: 38310435
[TBL] [Abstract][Full Text] [Related]
7. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
8. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
9. Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma.
Wang Y; Zhou S; Wang D; Wei T; Zhu J; Li Z
Front Endocrinol (Lausanne); 2021; 12():737638. PubMed ID: 34803909
[TBL] [Abstract][Full Text] [Related]
10. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
12. Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted
Razavi SA; Mahmanzar M; Nobakht M Gh BF; Zamani Z; Nasiri S; Hedayati M
J Pharm Biomed Anal; 2024 Apr; 241():115946. PubMed ID: 38241910
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population.
Cantara S; Pilli T; Sebastiani G; Cevenini G; Busonero G; Cardinale S; Dotta F; Pacini F
J Clin Endocrinol Metab; 2014 Nov; 99(11):4190-8. PubMed ID: 25057879
[TBL] [Abstract][Full Text] [Related]
14. Altered TEG Parameters Identify Hypercoagulablilty and are of Diagnosis Value for Papillary Thyroid Carcinoma Patients.
Lu S; Kang R; Wang Y; Zhu M; Zhao L; Xu Q; Song Y; Liu C
Exp Clin Endocrinol Diabetes; 2020 May; 128(5):297-302. PubMed ID: 30235493
[TBL] [Abstract][Full Text] [Related]
15. Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?
Selek A; Cetinarslan B; Tarkun I; Canturk Z; Ustuner B; Akyay Z
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1677-1681. PubMed ID: 27933384
[TBL] [Abstract][Full Text] [Related]
16. Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer.
Zhang T; Zhang H; He L; Wang Z; Dong W; Sun W; Zhang P
Med Sci Monit; 2018 Mar; 24():1614-1623. PubMed ID: 29553126
[TBL] [Abstract][Full Text] [Related]
17. Assessment Of Plasma B-Catenin Concentration As Biomarker Of Thyroid Cancer.
Bełdowski M
Pol Przegl Chir; 2015 Jul; 87(7):340-5. PubMed ID: 26351788
[TBL] [Abstract][Full Text] [Related]
18. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
20. New evidence on tumor suppressor activity of PTEN and KLLN in papillary thyroid carcinoma.
Razavi SA; Salehipour P; Gholami H; Sheikholeslami S; Zarif-Yeganeh M; Yaghmaei P; Modarressi MH; Hedayati M
Pathol Res Pract; 2021 Sep; 225():153586. PubMed ID: 34425332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]